Therapeutic strategies to prevent renal fibrosis include targeting epithelial cell cycle arrest in G2‐M phase, which mediates fibrosis via JNK signalling, and eliminating G2/M‐arrested tubular cells through downstream regulatory pathways [5]. The gene discussed is MAPK8; the disease is renal fibrosis.